Drug:
Reaction: THERAPY INTERRUPTED
20250101 - 20251231
No. 1101 - 1200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1101 | 24997193 |
US |
77 | 2 |
Product dose omission issue, Therapy interrupted, Insurance issue, |
||||
LENALIDOMIDE, |
||||
| 1102 | 24997211 |
US |
||
Insomnia, Therapy interrupted, Incorrect dose administered, |
||||
RELUGOLIX, RELUGOLIX, APALUTAMIDE, ALLOPURINOL, GABAPENTIN, |
||||
| 1103 | 24997237 |
US |
1 | |
Therapy interrupted, Condition aggravated, |
||||
APREMILAST, |
||||
| 1104 | 25003343 |
73 | ||
Infection, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 1105 | 25003769 |
78 | ||
Nasopharyngitis, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 1106 | 25003781 |
67 | 2 | |
Influenza, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 1107 | 25003815 |
82 | 1 | |
Dyspnoea, Chest pain, Atrial fibrillation, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1108 | 25003821 |
64 | 2 | |
Nasopharyngitis, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 1109 | 25003863 |
1 | ||
Hospitalisation, Therapy interrupted, |
||||
MACITENTAN, SELEXIPAG, |
||||
| 1110 | 25003865 |
57 | 2 | |
Cystitis, COVID-19, Therapy interrupted, |
||||
ABATACEPT, ABATACEPT, |
||||
| 1111 | 25003867 |
82 | 1 | |
Rash macular, Therapy interrupted, |
||||
| 1112 | 24988282 |
US |
75 | 2 |
Renal failure, Blood cholesterol increased, Therapy interrupted, |
||||
OBETICHOLIC ACID, OBETICHOLIC ACID, OBETICHOLIC ACID, ONABOTULINUMTOXINA, |
||||
| 1113 | 24988292 |
US |
74 | 2 |
Ataxia, Fall, Hepatic fibrosis, Hepatic cirrhosis, Dizziness, Gastritis, Oesophagitis, Dyspepsia, Vomiting, Nausea, Discoloured vomit, Diverticulum intestinal, Weight increased, Osteopenia, Memory impairment, Dyspnoea, Stress, Anxiety, Faeces soft, Defaecation urgency, Cough, Varices oesophageal, Scoliosis, Hiatus hernia, Oedema peripheral, Presyncope, Fatigue, Pruritus, Therapy interrupted, |
||||
OBETICHOLIC ACID, OBETICHOLIC ACID, OBETICHOLIC ACID, OBETICHOLIC ACID, OBETICHOLIC ACID, OBETICHOLIC ACID, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, URSODIOL, URSOSIOL, HYDROCHLOROTHIAZIDE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL, MECLIZINE, CEPHALEXIN, SELENIUM, FISH OIL, ERGOCALCIFEROL, CALCIUM CARBONATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LATANOPROST, AMLODIPINE BESYLATE, ROSUVASTATIN CALCIUM, FENOFIBRATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, KETOROLAC TROMETHAMINE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, |
||||
| 1114 | 24988315 |
US |
||
Loss of personal independence in daily activities, Symptom recurrence, Therapy interrupted, Drug ineffective, |
||||
EFGARTIGIMOD ALFA, AZATHIOPRINE, |
||||
| 1115 | 24988417 |
US |
56 | 1 |
Product prescribing issue, Therapy interrupted, |
||||
| 1116 | 24988505 |
CA |
73 | 2 |
Abdominal distension, Adverse event, Dyspepsia, Gastrointestinal disorder, Immune thrombocytopenia, Infusion related reaction, Injection site swelling, Localised infection, Platelet count decreased, Postoperative wound infection, Potentiating drug interaction, Regurgitation, Therapy interrupted, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, DESVENLAFAXINE SUCCINATE, FOLIC ACID, HYDROXYCHLOROQUINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METHOTREXATE, METHOTREXATE SODIUM, MIRTAZAPINE, PREDNISONE, RISPERIDONE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ERGOCALCIFEROL, |
||||
| 1117 | 24988525 |
US |
66 | 2 |
Inappropriate schedule of product administration, Product supply issue, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 1118 | 24988899 |
CA |
9 | 1 |
Dizziness, Fear of injection, Injection site pain, Intentional dose omission, Malaise, Nausea, Screaming, Tremor, Therapy interrupted, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, |
||||
| 1119 | 24989262 |
US |
64 | 2 |
Intestinal obstruction, Neutrophilia, Therapy interrupted, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 1120 | 24989484 |
US |
5 | 2 |
Pneumonitis, Influenza, Pyrexia, Cough, Therapy interrupted, |
||||
CETIRIZINE HYDROCHLORIDE, EPINEPHRINE, |
||||
| 1121 | 24989598 |
US |
76 | 2 |
Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1122 | 24989842 |
US |
2 | |
Myocardial infarction, Ill-defined disorder, White blood cell disorder, Therapy interrupted, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1123 | 24990157 |
US |
70 | 1 |
Product distribution issue, Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 1124 | 24990230 |
US |
2 | |
Rheumatoid arthritis, Feeling abnormal, Therapy interrupted, Product dose omission issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 1125 | 24990442 |
US |
1 | |
Psoriatic arthropathy, Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 1126 | 24990443 |
US |
62 | 2 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1127 | 24990741 |
CA |
||
Hypotension, Loss of consciousness, Therapy interrupted, |
||||
PATISIRAN, PATISIRAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FAMOTIDINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RANITIDINE, CIMETIDINE, VITAMIN A, IRON, RISEDRONATE SODIUM, GABAPENTIN, DIFLUNISAL, |
||||
| 1128 | 24990770 |
2 | ||
Pneumonia, Therapy interrupted, |
||||
LENALIDOMIDE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1129 | 24990897 |
2 | ||
Pneumonia, Cerebrovascular accident, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1130 | 24990982 |
US |
59 | 1 |
Dizziness, Therapy interrupted, Insurance issue, Tricuspid valve incompetence, Hypercholesterolaemia, Essential hypertension, Aortic valve stenosis, Erectile dysfunction, Off label use, Diastolic dysfunction, |
||||
MAVACAMTEN, MAVACAMTEN, MAVACAMTEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FERROUS SULFATE, GLIPIZIDE, GLIPIZIDE, INSULIN GLARGINE, LOVASTATIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, POTASSIUM CHLORIDE, LEVOTHYROXINE SODIUM, AMLODIPINE, BUMETANIDE, EMPAGLIFLOZIN, DULAGLUTIDE, METOPROLOL SUCCINATE, LORAZEPAM, INSULIN GLARGINE, GLYBURIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 1131 | 24991220 |
US |
63 | 2 |
Product dispensing issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1132 | 24991256 |
US |
||
Migraine, Therapy interrupted, |
||||
LONAPEGSOMATROPIN-TCGD, |
||||
| 1133 | 24991534 |
US |
69 | 1 |
Back pain, Hypoaesthesia, Upper respiratory tract infection, Bronchitis, Fatigue, Therapy interrupted, Insurance issue, |
||||
LENALIDOMIDE, |
||||
| 1134 | 24991662 |
CN |
||
Ultrafiltration failure, Oedema, Product quality issue, Therapy interrupted, Product availability issue, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 1135 | 24991690 |
US |
70 | 1 |
Product supply issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1136 | 24991730 |
US |
69 | 1 |
Therapy interrupted, Insurance issue, |
||||
| 1137 | 24991792 |
US |
1 | |
Parkinson^s disease, Therapy interrupted, |
||||
ROTIGOTINE, |
||||
| 1138 | 24991797 |
81 | 1 | |
Blood lactic acid increased, Hypotension, Acute kidney injury, Therapy interrupted, |
||||
FUROSEMIDE, CLONIDINE HYDROCHLORIDE, CLONIDINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 1139 | 24991912 |
US |
62 | 2 |
Product distribution issue, Therapy interrupted, |
||||
| 1140 | 24991957 |
US |
57 | 2 |
Deafness, Diverticulitis, Tympanic membrane perforation, Streptococcal infection, Epistaxis, Cellulitis, Influenza, Arthralgia, Back pain, Neck pain, Therapy interrupted, Inability to afford medication, |
||||
CERTOLIZUMAB PEGOL, ESTRADIOL AND NORETHINDRONE ACETATE, |
||||
| 1141 | 24991970 |
US |
40 | 2 |
Headache, Nausea, Vomiting, Condition aggravated, Therapy interrupted, |
||||
| 1142 | 24992334 |
US |
70 | 1 |
Therapy interrupted, Device difficult to use, Drug dose omission by device, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 1143 | 24994282 |
76 | 1 | |
Anaemia, Renal haematoma, Haemorrhage, Therapy interrupted, |
||||
APIXABAN, |
||||
| 1144 | 24994392 |
59 | 1 | |
Diabetic ketoacidosis, Product dose omission in error, Therapy interrupted, |
||||
EMPAGLIFLOZIN, |
||||
| 1145 | 24994395 |
62 | 1 | |
Euglycaemic diabetic ketoacidosis, Toxic encephalopathy, Metabolic acidosis, Therapy interrupted, |
||||
EMPAGLIFLOZIN, |
||||
| 1146 | 24994504 |
63 | ||
Hyperglycaemia, Euglycaemic diabetic ketoacidosis, Ketogenic diet, Therapy interrupted, |
||||
EMPAGLIFLOZIN, |
||||
| 1147 | 24994508 |
38 | ||
Influenza, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 1148 | 24994514 |
45 | 2 | |
Dizziness, Dyspnoea, Feeling hot, Infusion related reaction, Therapy interrupted, Nausea, |
||||
FERUMOXYTOL, |
||||
| 1149 | 24994518 |
74 | 2 | |
Foot operation, Product use issue, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 1150 | 24994614 |
25 | 2 | |
Headache, Decreased appetite, Therapy change, Arthralgia, Myalgia, Pyrexia, Ocular hyperaemia, Erythema, Syncope, Therapy interrupted, Paraesthesia, Neuralgia, Muscle spasms, White blood cell count increased, Iron deficiency, Red blood cell sedimentation rate increased, Blood creatine phosphokinase increased, C-reactive protein increased, |
||||
MODAFINIL, |
||||
| 1151 | 24994834 |
79 | 2 | |
Pneumonia streptococcal, Respiratory syncytial virus infection, Pneumonia, Therapy interrupted, |
||||
| 1152 | 24994849 |
68 | 2 | |
Malaise, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 1153 | 24994963 |
2 | ||
Therapy interrupted, |
||||
TADALAFIL, SELEXIPAG, |
||||
| 1154 | 24995070 |
42 | ||
Therapy interrupted, Migraine, Anaphylactic reaction, Product formulation issue, |
||||
PROPRANOLOL HYDROCHLORIDE, PROMETHAZINE, TORSEMIDE, PANTOPRAZOLE, LORAZEPAM, FLUCONAZOLE, HYDROXYZINE, CETIRIZINE HYDROCHLORIDE, |
||||
| 1155 | 24983319 |
US |
||
Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, APALUTAMIDE, CALCIUM, ERGOCALCIFEROL, HYDRALAZINE HYDROCHLORIDE, CARVEDILOL, |
||||
| 1156 | 24983333 |
US |
||
Pain, Cough, Influenza like illness, Hot flush, Blood glucose increased, Arthralgia, Therapy interrupted, |
||||
RELUGOLIX, RELUGOLIX, CARVEDILOL, FERROUS SULFATE, HYDRALAZINE HYDROCHLORIDE, LISINOPRIL, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE AND PHENYLEPHRINE HYDROCHLORIDE, |
||||
| 1157 | 24983338 |
US |
||
Dry mouth, Fatigue, Flushing, Incorrect dose administered, Therapy interrupted, |
||||
RELUGOLIX, ENZALUTAMIDE, |
||||
| 1158 | 24983401 |
AT |
42 | 1 |
Pulmonary cavitation, Body temperature increased, Cough, Therapy interrupted, |
||||
AMIKACIN, AMIKACIN, |
||||
| 1159 | 24984290 |
CA |
75 | 2 |
Drug ineffective, Dyspnoea, Fatigue, Incorrect dose administered, Infusion site erythema, Infusion site pain, Loss of personal independence in daily activities, Lymphoma, Pain, Respiratory disorder, Therapy interrupted, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 1160 | 24984593 |
US |
||
Surgery, Pollakiuria, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 1161 | 24984710 |
CA |
84 | 2 |
Death, Asthenia, Blood pressure increased, Confusional state, Dementia, Diplopia, Fall, Fatigue, Food refusal, Gait inability, Headache, Hypersomnia, Hypophagia, Incorrect dose administered, Incorrect drug administration rate, Injection site bruising, Off label use, Pain, Poor venous access, Skin cancer, Somnolence, Therapy interrupted, Trigeminal neuralgia, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, APIXABAN, LORAZEPAM, DIGOXIN, DIGOXIN, EZETIMIBE, FUROSEMIDE, GABAPENTIN, GLYCOPYRROLATE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METHADONE HYDROCHLORIDE, METHADONE, METOPROLOL TARTRATE, METOPROLOL, OLANZAPINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, SENNOSIDES, ERGOCALCIFEROL, |
||||
| 1162 | 24984713 |
US |
||
Pain, Urinary retention, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 1163 | 24984891 |
US |
||
Fracture, Fall, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 1164 | 24984927 |
US |
1 | |
Therapy interrupted, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1165 | 24985013 |
US |
80 | 2 |
Rheumatoid arthritis, Autoimmune thyroiditis, Spinal compression fracture, Rheumatoid arthritis-associated interstitial lung disease, Bronchiectasis, Aortic arteriosclerosis, Urticaria chronic, COVID-19, Osteopenia, Blood pressure decreased, Genital herpes simplex, Pain in extremity, Arthropathy, Therapy interrupted, |
||||
ALENDRONATE SODIUM, PREDNISONE, ETANERCEPT, ETANERCEPT, ADALIMUMAB-ATTO, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, GABAPENTIN, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, LEVOTHYROXINE, |
||||
| 1166 | 24985075 |
US |
||
Coronary artery bypass, Night sweats, Insomnia, Hot flush, Therapy interrupted, |
||||
RELUGOLIX, SACUBITRIL AND VALSARTAN, APIXABAN, AMLODIPINE, CARVEDILOL, ROSUVASTATIN, ABIRATERONE ACETATE, PANTOPRAZOLE SODIUM, ROSUVASTATIN, ENZALUTAMIDE, |
||||
| 1167 | 24985210 |
US |
59 | |
Therapy interrupted, Off label use, |
||||
LENALIDOMIDE, |
||||
| 1168 | 24985332 |
US |
||
Therapy interrupted, Influenza like illness, |
||||
| 1169 | 24985401 |
US |
1 | |
Hallucination, Bedridden, Therapy interrupted, Product use complaint, |
||||
PIMAVANSERIN TARTRATE, RIVASTIGMINE, ALPRAZOLAM, MESALAMINE, OXYBUTYNIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, CARBIDOPA AND LEVODOPA, ERGOCALCIFEROL, ROTIGOTINE, |
||||
| 1170 | 24985665 |
US |
70 | 1 |
Inability to afford medication, Therapy interrupted, |
||||
| 1171 | 24985729 |
US |
61 | 2 |
Transient ischaemic attack, Memory impairment, Injection site haemorrhage, Device difficult to use, Incorrect disposal of product, Blood cholesterol increased, Epistaxis, Therapy interrupted, Overweight, |
||||
EVOLOCUMAB, ALPRAZOLAM, ALPRAZOLAM, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, MONTELUKAST, MONTELUKAST, PANTOPRAZOLE, PANTOPRAZOLE, TIZANIDINE, TIZANIDINE, VITAMIN A, VITAMIN A, PHYTONADIONE, PHYTONADIONE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, EZETIMIBE, EZETIMIBE, VITAMIN E, CREAM, EVOLOCUMAB, |
||||
| 1172 | 24985750 |
1 | ||
Pneumonia, Fall, Back pain, Therapy interrupted, General physical health deterioration, Eye disorder, |
||||
LENALIDOMIDE, ACYCLOVIR, CARVEDILOL, APIXABAN, SACUBITRIL AND VALSARTAN, FINASTERIDE, FUROSEMIDE, GUAIFENESIN, |
||||
| 1173 | 24986052 |
1 | ||
Hospitalisation, Therapy interrupted, |
||||
DASATINIB, |
||||
| 1174 | 24986101 |
US |
||
Therapy interrupted, |
||||
ABATACEPT, |
||||
| 1175 | 24986510 |
71 | 1 | |
Post procedural infection, Therapy interrupted, Rheumatoid arthritis, Loss of personal independence in daily activities, |
||||
ETANERCEPT, |
||||
| 1176 | 24986556 |
US |
70 | 1 |
Therapy interrupted, Insurance issue, |
||||
LENALIDOMIDE, |
||||
| 1177 | 24986585 |
US |
||
Spinal fracture, Influenza like illness, Therapy interrupted, Bone density abnormal, |
||||
ROMOSOZUMAB-AQQG, ROMOSOZUMAB-AQQG, |
||||
| 1178 | 24986614 |
55 | 2 | |
Hospitalisation, Therapy interrupted, |
||||
RUXOLITINIB, |
||||
| 1179 | 24986677 |
US |
74 | 1 |
Insurance issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1180 | 24986714 |
GB |
1 | |
Schizophrenia, Treatment noncompliance, Therapy interrupted, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 1181 | 24986815 |
US |
2 | |
Hypoaesthesia, Musculoskeletal stiffness, Insurance issue, Pain, Inability to afford medication, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 1182 | 24986825 |
US |
1 | |
Rheumatoid arthritis, Viral infection, Therapy interrupted, Insurance issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 1183 | 24987459 |
|||
Therapy interrupted, |
||||
LISDEXAMFETAMINE DIMESYLATE, |
||||
| 1184 | 24987489 |
IL |
13 | 2 |
Injection site pain, Patient-device incompatibility, Therapy interrupted, Inappropriate schedule of product administration, |
||||
SOMATROGON-GHLA, SOMATROGON-GHLA, |
||||
| 1185 | 24987830 |
US |
53 | 2 |
Device difficult to use, Product communication issue, Drug dose omission by device, Therapy interrupted, |
||||
ADALIMUMAB-ATTO, ADALIMUMAB-ATTO, |
||||
| 1186 | 24987918 |
CA |
1 | |
Therapy interrupted, Dependence, |
||||
CLOZAPINE, |
||||
| 1187 | 24987952 |
US |
71 | 1 |
Diarrhoea, Ageusia, Product distribution issue, Therapy interrupted, |
||||
LENALIDOMIDE, |
||||
| 1188 | 24989713 |
57 | 2 | |
Illness, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 1189 | 24989714 |
71 | 2 | |
Illness, Therapy interrupted, |
||||
SECUKINUMAB, |
||||
| 1190 | 24989929 |
2 | ||
Tremor, Seizure, Cardiac arrest, Therapy interrupted, |
||||
OFATUMUMAB, |
||||
| 1191 | 24990174 |
1 | ||
Pneumonia, Fall, Back pain, Therapy interrupted, Eye disorder, |
||||
LENALIDOMIDE, CARVEDILOL, SACUBITRIL AND VALSARTAN, FINASTERIDE, FUROSEMIDE, |
||||
| 1192 | 24990266 |
60 | 2 | |
Influenza, Herpes zoster, Therapy interrupted, |
||||
IXEKIZUMAB, |
||||
| 1193 | 24990269 |
1 | ||
Therapy interrupted, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 1194 | 24990332 |
31 | 2 | |
Therapy interrupted, Migraine with aura, Withdrawal syndrome, Headache, |
||||
VILOXAZINE HYDROCHLORIDE, MIRTAZAPINE, LEVONORGESTREL, |
||||
| 1195 | 24990379 |
34 | 2 | |
Insomnia, Therapy interrupted, |
||||
SEMAGLUTIDE, |
||||
| 1196 | 24978739 |
US |
2 | |
Rheumatoid arthritis, Therapy interrupted, Insurance issue, |
||||
CERTOLIZUMAB PEGOL, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, |
||||
| 1197 | 24978812 |
US |
80 | 1 |
Respiratory tract congestion, Cough, Influenza, Product distribution issue, Therapy interrupted, Constipation, |
||||
| 1198 | 24978835 |
US |
67 | 2 |
Device difficult to use, Drug dose omission by device, Therapy interrupted, Off label use, Wrong technique in product usage process, Product preparation error, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1199 | 24978957 |
US |
2 | |
Therapy interrupted, |
||||
| 1200 | 24979032 |
US |
63 | 2 |
Therapy interrupted, Product prescribing issue, |
||||
MAVACAMTEN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28